Error - Could not copy link. Try again
Page link copied
Weekly Round-up

Medicinal Cannabis Matters | Friday roundup 30th May 2025


Medicinal Cannabis Matters | Friday roundup 30th May 2025

In Medicann’s news roundup this week, we highlight new studies showing the benefits of medicinal cannabis managing three different conditions. So if you, or someone you know, is living with musculoskeletal pain, having chemotherapy, or experiencing sleep apnea, read on to find out more about this new research, just in. 

Drastic improvements in sleep quality for 39.4% of patients

In this new report, where over 3000 patients enrolled onto the Minnesota Medical Cannabis Program it found that patients were able to improve their symptoms of sleep disturbance and fatigue after starting medical cannabis. 

Read more

93% of Musculoskeletal pain patients strongly agreed that medicinal cannabis improved their primary symptoms.

With musculoskeletal impairments encompassing more than 150 different diseases and conditions affecting muscles, bones, joints, and surrounding connective tissues, this new report shows promise for patients being able to improve their ability to function and participate in daily activities.

Read more

Medicinal cannabis can boost cancer treatment while reducing side effects, study finds

Medicinal cannabis is already used to treat chemotherapy-induced nausea and vomiting, as well as tumour-related pain, but now researchers from the Institute of Pharmacology and Toxicology at Rostock University Medical Center in Germany have revealed that when combined with chemotherapy, cannabinoids appear to help kill cancer cells more effectively than chemotherapy alone. 

Read more

If you, or someone you know is managing one of these conditions, and wants to explore the potential of medicinal cannabis for managing your health, get started today by completing our Eligibility Checker

Medicann Team

Disclaimer: 

This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann. 

Other articles